| Jain V, Prasad V, Jadhav P, et al.
Preparation and performance evaluation of saquinavir laden cationic submicron emulsions. [Journal Article]
Drug Deliv 2009 Jan; 16(1):37-44.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tsang CS, Hong I
HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces. [JOURNAL ARTICLE]
Mycoses 2009 Jun 15.
Abstract | Full Citation | Find Related Articles | | Alcaro S, Artese A, Ceccherini-Silberstein F, et al.
Molecular Dynamics and Free Energy Studies on the Wild-Type and Mutated HIV-1 Protease Complexed with Four Approved Drugs: Mechanism of Binding and Drug Resistance. [JOURNAL ARTICLE]
J Chem Inf Model 2009 Jun 18.
Abstract | Full Citation | Find Related Articles | | von Hentig N, Lötsch J
CYP3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in HIV-1 infected adults. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Jun 15.
Abstract | Full Citation | Find Related Articles | | Jamois C, Smith P, Morrison R, et al.
Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy. [Journal Article]
Addict Biol 2009 Jul; 14(3):321-7.
Abstract | Full Citation | Find Related Articles | | Fenneteau F, Poulin P, Nekka F
Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. [JOURNAL ARTICLE]
J Pharm Sci 2009 May 28.
Abstract | Full Citation | Find Related Articles | | van der Lugt J, Colbers A, Molto J, et al.
The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(3):443-450.
Abstract | Full Citation | | Rahi MM, Heikkinen TM, Hakala KE, et al.
The effect of probenecid and mk-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta. [JOURNAL ARTICLE]
Eur J Pharm Sci 2009 May 16.
Abstract | Full Citation | Find Related Articles | | van der Lugt J, Gorowara M, Avihingsanon A, et al.
Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2009 Jun 1; 23(9):1176-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bunupuradah T, van der Lugt J, Kosalaraksa P, et al.
Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(2):241-248.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
